EQS Newsfeed

Corpare News, Press, Analysis

Made with ❤ von BGFL
#BGFLapp * beta

EQS News is by far the most important platform for official company news. Boersengefluester.de combines the latest ad-hoc announcements or other company news from our database, meaningful share charts and other useful links from the BGFL data pool, thus creating added value for investors who prefer to obtain timely and meaningful information from the original source. Tip: You are also welcome to use our newsfeed focussing on the latest analyst research to round things off.

05.05.2026 07:46AM

Impressive start to year 2026 – guidance raised

Elmos Semiconductor SE: Impressive start to year 2026 – guidance raised Sales increase to 152.5 million Euro in the first quarter, up 20.2% year-on-year, EBIT margin improves to 23.8% and adjusted free cash flow reaches a strong 26.7% of sales Leverkusen, May 5, 2026: Elmos Semiconductor SE (FSE: ELG) has, as expected, started the new year with  [ … ]
04.05.2026 04:13PM

Elmos Semiconductor SE raises guidance for fiscal year 2026

Elmos Semiconductor SE raises guidance for fiscal year 2026 Publication of inside information pursuant to Article 17 of Regulation (EU) No. 596/2014 Elmos Semiconductor SE (WKN 567710, ISIN DE0005677108) Elmos Semiconductor SE (FSE: ELG) has raised its guidance for fiscal year 2026 based on on the very strong performance in the first three months [ … ]
04.05.2026 07:30AM

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall

  Joint Evotec–Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelines Collaboration leverages Evotec’s end-to-end integrated AI/ML-driven R&D capabilities and Almirall’s dermatology expertise   Hamburg, Germany, May 4, 2026 – Evotec SE (NASDAQ: EVO; Fran [ … ]
30.04.2026 07:30AM

Evotec Receives Grants to Advance Tuberculosis Treatment

  Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testing New funding from the Gates Foundation extends Evotec’s commitment to create more effective tuberculosis treatment regimens   Hamburg, Germany, April 30, 2026 – Evotec SE (NASDAQ: EVO; [ … ]
29.04.2026 10:05PM

Evotec Announces New Nomination to Board of Directors

Evotec Announces New Nomination to Board of Directors Nomination of Dr. Wolfgang Hofmann as independent Supervisory Board member to further strengthen oversight and governance capabilities Conclusion of cooperation agreement with MAK Capital following constructive discussions, reflecting Evotec’s commitment to open shareholder dialogue Annual Ge [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
If desired, the news can be limited to certain indices (DAX, MDAX, etc.) or market segments (Prime Standard, General Standard, Scale, etc.).
Dataselect Tool Family
          EQS Newsfeed          
          Qualitätsjournalismus · Made in Germany © 2026          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 by Gereon Kruse #BGFL